| __timestamp | Axsome Therapeutics, Inc. | Pharming Group N.V. |
|---|---|---|
| Wednesday, January 1, 2014 | 4279200 | 14182353 |
| Thursday, January 1, 2015 | 6776987 | 15503028 |
| Friday, January 1, 2016 | 21199860 | 16183585 |
| Sunday, January 1, 2017 | 19957616 | 22382849 |
| Monday, January 1, 2018 | 23495055 | 33038206 |
| Tuesday, January 1, 2019 | 53647067 | 31777040 |
| Wednesday, January 1, 2020 | 70244579 | 41464134 |
| Friday, January 1, 2021 | 58060725 | 67178053 |
| Saturday, January 1, 2022 | 57947447 | 52531000 |
| Sunday, January 1, 2023 | 97944000 | 68914000 |
| Monday, January 1, 2024 | 187077000 |
Cracking the code
In the competitive world of pharmaceuticals, innovation is key to staying ahead. Over the past decade, Axsome Therapeutics, Inc. and Pharming Group N.V. have been at the forefront of this race. From 2014 to 2023, Axsome Therapeutics has consistently increased its investment in research and development (R&D), culminating in a staggering 128% increase by 2023 compared to 2014. Meanwhile, Pharming Group N.V. has also shown a robust commitment, with a 386% increase in R&D spending over the same period.
While both companies have shown dedication to innovation, Axsome's R&D expenses peaked in 2023, reaching nearly 98 million, a 69% increase from the previous year. Pharming, on the other hand, saw its highest R&D investment in 2021, with a 61% increase from 2020. This data highlights the dynamic strategies these companies employ to drive innovation and maintain their competitive edge.
Comparing Innovation Spending: Johnson & Johnson and Pharming Group N.V.
Research and Development: Comparing Key Metrics for Bristol-Myers Squibb Company and Axsome Therapeutics, Inc.
R&D Spending Showdown: Genmab A/S vs Axsome Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Pharming Group N.V. and Axsome Therapeutics, Inc.
Pharming Group N.V. or Grifols, S.A.: Who Invests More in Innovation?
Research and Development Investment: Pharming Group N.V. vs Alkermes plc
R&D Insights: How Pharming Group N.V. and Corcept Therapeutics Incorporated Allocate Funds
R&D Insights: How Pharming Group N.V. and MannKind Corporation Allocate Funds
R&D Spending Showdown: Pharming Group N.V. vs Dynavax Technologies Corporation
Comparing Innovation Spending: Pharming Group N.V. and Novavax, Inc.
Research and Development: Comparing Key Metrics for Axsome Therapeutics, Inc. and TG Therapeutics, Inc.
Research and Development Investment: Axsome Therapeutics, Inc. vs Alpine Immune Sciences, Inc.